What question did this study set out to answer?

To evaluate whether implementing a diagnosis-related group payment pilot improved the quality and reduced the costs of acute myocardial infarction care compared to standard hospital payment systems.

October 5, 2019Social Science & MedicineOpen Access

Beijing's diagnosis-related group payment reform pilot: Impact on quality of acute myocardial infarction care

View Full Paper

Ask AI

Bookmark

Authors

WJWeiyan Jian MLMing Lu GLGuofeng Liu

Discussion

Member takes

Overview

Difference-in-differences analysis shows no improvement in acute myocardial infarction care quality following bundled payment reform, suggesting cost controls alone do not drive clinical quality.

Key Points

To evaluate whether implementing a diagnosis-related group payment pilot improved the quality and reduced the costs of acute myocardial infarction care compared to standard hospital payment systems.
Conducted a difference-in-differences regression analysis comparing pilot hospitals implementing diagnosis-related group payments to control hospitals in Beijing, China.
Assessed quality indicators including acute and discharge use of aspirin and β-blockers, statin use at discharge, in-hospital mortality, and 30-day readmission rates.
Implementation of the diagnosis-related group payment pilot did not improve guideline-directed medication use, mortality, or readmissions for acute myocardial infarction compared to control facilities.
Cost-containment payment mechanisms lacking explicit clinical quality incentives failed to drive measurable gains in acute cardiovascular care delivery.

Cite This Study

Jian et al. (2019) studied this question.

synapsesocial.com/papers/6a01ba63bd6301933f5cb548 https://doi.org/10.1016/j.socscimed.2019.112590

View Full Paper

Ask AI

Bookmark

October 5, 2019Social Science & MedicineOpen Access

Beijing's diagnosis-related group payment reform pilot: Impact on quality of acute myocardial infarction care

View Full Paper

Ask AI

Bookmark

Authors

WJWeiyan Jian MLMing Lu GLGuofeng Liu

Discussion

Member takes

Overview

Difference-in-differences analysis shows no improvement in acute myocardial infarction care quality following bundled payment reform, suggesting cost controls alone do not drive clinical quality.

Key Points

To evaluate whether implementing a diagnosis-related group payment pilot improved the quality and reduced the costs of acute myocardial infarction care compared to standard hospital payment systems.
Conducted a difference-in-differences regression analysis comparing pilot hospitals implementing diagnosis-related group payments to control hospitals in Beijing, China.
Assessed quality indicators including acute and discharge use of aspirin and β-blockers, statin use at discharge, in-hospital mortality, and 30-day readmission rates.
Implementation of the diagnosis-related group payment pilot did not improve guideline-directed medication use, mortality, or readmissions for acute myocardial infarction compared to control facilities.
Cost-containment payment mechanisms lacking explicit clinical quality incentives failed to drive measurable gains in acute cardiovascular care delivery.

Cite This Study

Jian et al. (2019) studied this question.

synapsesocial.com/papers/6a01ba63bd6301933f5cb548 https://doi.org/10.1016/j.socscimed.2019.112590

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark